Difference between revisions of "Dihydropyrimidine dehydrogenase deficiency"
Jump to navigation
Jump to search
(create) |
|||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
'''Dihydropyrimidine dehydrogenase deficiency''' is an enzyme deficiency that is associated with toxicity to 5-fluorouracil.<ref>{{cite journal | | '''Dihydropyrimidine dehydrogenase deficiency''', abbreviated '''DPD''', is an enzyme deficiency that is associated with toxicity to 5-fluorouracil (5-FU).<ref>{{cite journal |authors=Ezzeldin H, Diasio R |title=Dihydropyrimidine dehydrogenase deficiency, a pharmacogenetic syndrome associated with potentially life-threatening toxicity following 5-fluorouracil administration |journal=Clin Colorectal Cancer |volume=4 |issue=3 |pages=181–9 |date=September 2004 |pmid=15377401 |doi=10.3816/ccc.2004.n.018 |url=}}</ref> | ||
==See also== | ==See also== | ||
Latest revision as of 16:08, 23 February 2024
Dihydropyrimidine dehydrogenase deficiency, abbreviated DPD, is an enzyme deficiency that is associated with toxicity to 5-fluorouracil (5-FU).[1]
See also
References
- ↑ Ezzeldin H, Diasio R (September 2004). "Dihydropyrimidine dehydrogenase deficiency, a pharmacogenetic syndrome associated with potentially life-threatening toxicity following 5-fluorouracil administration". Clin Colorectal Cancer 4 (3): 181–9. doi:10.3816/ccc.2004.n.018. PMID 15377401.